New form discovery for the analgesics flurbiprofen and sulindac facilitated by polymer-induced heteronucleation.
The selection and discovery of new crystalline forms is a longstanding issue in solid-state chemistry of critical importance because of the effect molecular packing arrangement exerts on materials properties. Polymer-induced heteronucleation has recently been developed as a powerful approach to discover and control the production of crystal modifications based on the insoluble polymer heteronucleant added to the crystallization solution. The selective nucleation and discovery of new crystal forms of the well-studied pharmaceuticals flurbiprofen (FBP) and sulindac (SUL) has been achieved utilizing this approach. For the first time, FBP form III was produced in bulk quantities and its crystal structure was also determined. Furthermore, a novel 3:2 FBP:H(2)O phase was discovered that nucleates selectively from only a few polymers. Crystallization of SUL in the presence of insoluble polymers facilitated the growth of form I single crystals suitable for structure determination. Additionally, a new SUL polymorph (form IV) was discovered by this method. The crystal forms of FBP and SUL are characterized by Raman and FTIR spectroscopies, X-ray diffraction, and differential scanning calorimetry.
Grzesiak
Adam L
AL
Department of Chemistry and Marcromolecular Science and Engineering Program, The University of Michigan, Ann Arbor, Michigan 48109-1055, USA.
Matzger
Adam J
AJ
D000700:Analgesics / Q000737:chemistry*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000737:chemistry; D002152:Calorimetry, Differential Scanning; D003460:Crystallization; D005480:Flurbiprofen / Q000737:chemistry*; D008958:Models, Molecular; D013059:Spectrum Analysis, Raman; D013467:Sulindac / Q000737:chemistry*; D013818:Thermogravimetry; D014961:X-Ray Diffraction
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013467:Sulindac; D005480:Flurbiprofen